Preparation method of microbubble preparation for ultrasonic diagnosis and treatment
An ultrasonic diagnosis and microbubble technology, applied in the field of tumor treatment, can solve problems such as unsatisfactory action spectrum, large toxicity and side effects of sound sensitizers, single components, etc., and achieve the stage of reducing gradient power. Ultrasonic response performance, the effect of improving the preparation effect
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Image
Examples
Embodiment 1
[0051] A method for preparing a microbubble preparation for ultrasonic diagnosis and treatment, the microbubble preparation is composed of a shell membrane layer and an internal cavity, comprising the following steps:
[0052] S1: Synthesis of metalloporphyrin complexes by chemical synthesis, the metalloporphyrin complexes are metalloporphyrin complexes (formula 1) with Ti as the central atom, such as figure 1 As shown, the metalloporphyrin complex was added into the albumin solution for ultrasonic treatment to obtain the albumin-wrapped metalloporphyrin complex, wherein the mass ratio of the metalloporphyrin complex to albumin was 1:80, ready to use ;
[0053] S2: Select the metalloporphyrin complex obtained in step S1, and proportion the components as follows in parts by weight: 37 parts of metalloporphyrin complex, 125 parts of phospholipid, 20 parts of saturated fatty acid, mix and disperse In an organic solvent of 40 times its volume, a mixed solution is obtained; wherei...
Embodiment 2
[0076] This embodiment is basically the same as Embodiment 1, and the difference is that the number of components of the mixed solution in step S2 is different, specifically:
[0077] S2: Select the metalloporphyrin complex obtained in step S1, and proportion the components in parts by weight as follows: 20 parts of metalloporphyrin complex, 50 parts of phospholipid, and 15 parts of saturated fatty acid, mix and disperse In an organic solvent of 20 times its volume, a mixed solution is obtained; wherein, the organic solvent is selected from acetone, and the phospholipid is selected from a mixture of phosphatidylglycerol and diphosphatidylglycerol in a mass ratio of 1:2; the Saturated fatty acids are selected from palmitic acid.
Embodiment 3
[0079] This embodiment is basically the same as Embodiment 1, and the difference is that the number of components of the mixed solution in step S2 is different, specifically:
[0080] S2: Select the metalloporphyrin complex obtained in step S1, and proportion the components in parts by weight as follows: 45 parts of metalloporphyrin complex, 150 parts of phospholipid, and 25 parts of saturated fatty acid, mix and disperse In an organic solvent of 50 times its volume, a mixed solution is obtained; wherein, the organic solvent is selected from acetone, and the phospholipid is selected from a mixture of phosphatidylglycerol and diphosphatidylglycerol in a mass ratio of 1:2; the Saturated fatty acids are selected from palmitic acid.
PUM
| Property | Measurement | Unit |
|---|---|---|
| diameter | aaaaa | aaaaa |
Abstract
Description
Claims
Application Information
Login to View More 


